Innventure (INV)
Commercializes corporate technologies through controlled industrial operating companies.
$0.8849
vs last close+0.00 (+0.55%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Cost of revenue | 0 | 0 | 0 | 0 | 1 | 4 | 0 | 3 | 10 | 6 | 5 | 5 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | −3 | 0 | −2 | −9 | −5 | −4 | −4 |
| 6 | 10 | 11 | 12 | 13 | 37 | 261 | 140 | 20 | 27 | 23 | 27 | |
| Research & development | 1 | 1 | 2 | 2 | 3 | 5 | 6 | 6 | 6 | 7 | 8 | 1 |
| 5 | 9 | 9 | 10 | 11 | 32 | 22 | 21 | 19 | 14 | 16 | 18 | |
| Selling & marketing | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| General & administrative | 4 | 8 | 8 | 8 | 9 | 30 | 20 | 19 | 17 | 12 | 13 | 14 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 233 | 113 | −6 | 6 | 0 | 9 |
| Operating income | −6 | −10 | −11 | −11 | −14 | −40 | −261 | −143 | −29 | −32 | −27 | −31 |
| −13 | −3 | 3 | 0 | 6 | −33 | 6 | −1 | −9 | −20 | −4 | −5 | |
| Interest expense | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 3 | 2 | −1 | 1 |
| Other non-operating income | 13 | 3 | −3 | 0 | −7 | 32 | −8 | −2 | 6 | 18 | 3 | 4 |
| Income before tax | −19 | −13 | −8 | −11 | −8 | −73 | −255 | −143 | −38 | −52 | −31 | −36 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | −3 | −1 | −2 | −4 | −6 | −10 | −2 |
| Net income from continuing operations | −19 | −13 | −8 | −11 | −8 | −70 | −254 | −141 | −35 | −46 | −21 | −35 |
| Net income | −19 | −13 | −5 | −7 | −2 | −62 | −143 | −84 | −28 | −38 | −21 | −27 |
| EPS, basic | −$0.44 | −$0.30 | −$0.12 | −$0.17 | −$0.05 | −$1.41 | −$3.10 | −$1.60 | −$0.51 | −$0.69 | −$0.38 | −$0.32 |
| EPS, diluted | −$0.44 | −$0.30 | −$0.12 | −$0.17 | −$0.05 | −$1.41 | −$3.10 | −$1.60 | −$0.51 | −$0.69 | −$0.38 | −$0.32 |
| Weighted average shares, basic | 43 | 43 | 43 | 44 | 45 | 44 | 46 | 53 | 56 | 54 | 54 | 83 |
| Weighted average shares, diluted | 43 | 43 | 43 | 44 | 45 | 44 | 46 | 53 | 56 | 54 | 54 | 83 |
| EBITDA | −19 | −13 | −7 | −11 | −7 | −67 | −248 | −135 | −29 | −44 | −24 | −30 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 5 | 6 | 6 | 6 | 6 | 6 | 6 |
| EBIT | −19 | −13 | −7 | −11 | −7 | −72 | −254 | −141 | −35 | −50 | −30 | −36 |
